Casandra
Casandra Test Code PG68376Version 1 (DRAFT)
Performing Lab
Catecholaminergic Polymorphic Ventricular Tachycardia Panel
Clinical Use
Order TestUse
Suitable for individuals with a clinical or suspected diagnosis of catecholaminergic polymorphic ventricular tachycardia (CPVT), their relatives who lack access to genetic variant information, or those with a family member presumed to have CPVT but not genetically tested.
Special Instructions
Includes reflex testing and is available with STAT testing options. Reports are available via the myPrevent portal.
Limitations
This test has not been cleared or approved by the US Food and Drug Administration.
Test Details
New York Approved
Methodology
NGS (CGP)
Biomarkers
The test utilizes Next-Generation Sequencing (NGS) with copy number variation (CNV) analysis to evaluate 11 genes associated with catecholaminergic polymorphic ventricular tachycardia.
NGS with CNV Analysis • CGP
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided